This inhibition of mitophagy by CDK9 inhibitors contributes to increased mitochondrial dysfunction, ultimately promoting apoptosis in hepatocellular carcinoma (Yao et al., 2022). Here, CDK9 is linked to hepatocellular carcinoma.